MA H945 | 2023-2024 | 193rd General Court

Note: Legislation replaced by H4634

Status

Spectrum: Moderate Partisan Bill (Democrat 27-2-1)
Status: Introduced on February 16 2023 - 25% progression
Action: 2024-05-09 - Accompanied a study order, see H4634
Text: Latest bill text (Introduced) [PDF]

Summary

For legislation to ensure prescription drug cost transparency and affordability. Financial Services.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

To ensure prescription drug cost transparency and affordability

Sponsors


History

DateChamberAction
2024-05-09HouseAccompanied a study order, see H4634
2024-02-22HouseReported favorably by committee and referred to the Joint Committee on Health Care Financing
2023-05-02JointHearing scheduled for 05/16/2023 from 10:00 AM-01:00 PM in A-2 and virtual
2023-02-16SenateSenate concurred
2023-02-16HouseReferred to the Joint Committee on Financial Services

Same As/Similar To

H4634 (Replaced by) 2024-05-09 - Reported, in part, by H962
H1056 (Similar To) 2024-05-30 - Accompanied a study order, see H4691

Massachusetts State Sources


Bill Comments

feedback